THE CARDIOVASCULAR EFFECTS OF LOW LEVELS OF IONIZED CALCIUM DURING MASSIVE TRANSFUSION

1978 ◽  
Vol 22 (4) ◽  
pp. 384
Author(s):  
W. S. HOWLAND ◽  
O. SCHWEIZER ◽  
G. C. CARLON ◽  
P. L. GOLDINER
2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S7-S8
Author(s):  
Maryam Salehi ◽  
Janetta Bryksin ◽  
Lisa Cole ◽  
Michael J Connor ◽  
Tammy Posey ◽  
...  

Abstract Continuous renal replacement therapy (CRRT) is a standard of care for critically ill patients according to the guidelines for Kidney Disease Improving Global Outcomes Clinical Practice. Within the CRRT dialysis instrument, blood requires anticoagulation with citrate with a goal to have ionized calcium (iCa) <0.4 mmol/L. In our hospital system, nephrologists who manage the therapy rotate through these hospitals, although in each of the hospitals, instruments that measure iCa are different. The objective of this study was to demonstrate the differences in measurement by these instruments. Method Twelve patient samples were drawn in triplicate and compared in the three different analyzers: RAPIDPoint, Nova Biomedical, and GEM4000 analyzers. One of the analyzers uses whole blood while the other two measure iCa in plasma. In one of the facilities, samples were spun, decapped, sent to the automated line outlet, and tested after having been exposed to air, and thus an experiment in another facility decapped the specimens for an hour and retested. Results Postfilter iCa measurements ranged from 0.18 to 0.64 mmol/L; however, range was different for each of the instruments: The Nova measurements averaged 0.55 mmol/L (range 0.42-0.64), the Rapid Point 0.36 (0.28-0.45), and the GEM 0.30 (0.18-0.39). The average difference between results of the Nova and GEM was 0.25 mmol/L, between Nova and RAPIDPoint 0.19 mmol/L, and GEM and RAPIDPoint 0.06 mmol/L. The differences between the values measured 1 hour after the sample had been decapped were negligible. Conclusion This study demonstrates inconsistency among instruments when measuring iCa in CRRT blood samples. The Nova analyzer tends to give higher results while the Rapid Point and GEM are lower and with values closer together. Currently, there is no reference material or reference method established for low iCa in CRRT samples. This study helped our clinicians understand the differences that occur between the different analyzers for low levels of iCa in CRRT blood samples.


2006 ◽  
Vol 25 (4) ◽  
pp. 653-660 ◽  
Author(s):  
Shigeki Toyoshima ◽  
Tatsuru Fukuda ◽  
Shigeru Masumi ◽  
Yoshifumi Nakashima ◽  
Yoshiro Kawaguchi ◽  
...  

2020 ◽  
Vol 58 (9) ◽  
pp. e171-e173 ◽  
Author(s):  
Fabrizio Cappellini ◽  
Rinaldo Brivio ◽  
Marco Casati ◽  
Annalisa Cavallero ◽  
Ernesto Contro ◽  
...  
Keyword(s):  

2008 ◽  
Vol 41 (18) ◽  
pp. 16
Author(s):  
DIANA MAHONEY
Keyword(s):  

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.


Sign in / Sign up

Export Citation Format

Share Document